A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy

Epilepsy Research

Volumn 83, Issue 2-3, 2009, Pages 152-156

  Chen, Yan ^a   Wu, Liwen ^a   Fang, Yue ^b   He, Zhiyi ^c   Peng, Bingwei ^a   Shen, Yan ^b   Xu, Qi ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CHRNA4; Mutation; Nocturnal frontal lobe epilepsy

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR BETA2; OXCARBAZEPINE; VALPROIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; ELECTROENCEPHALOGRAM; FEMALE; FRONTAL LOBE EPILEPSY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC SCREENING; HUMAN; MALE; MISSENSE MUTATION; NOCTURNAL FRONTAL LOBE EPILEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SEIZURE;

ADOLESCENT; ADULT; ARGININE; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; ELECTROENCEPHALOGRAPHY; EPILEPSY, FRONTAL LOBE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTIDINE; HUMANS; INFANT; MALE; MUTATION, MISSENSE; RECEPTORS, NICOTINIC; YOUNG ADULT;

EID: 58849120436     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.10.009     Document Type: Article

References (31)

1. Aridon P., Marini C., Di Resta C., Brilli E., De Fusco M., Politi F., Parrini E., Manfredi I., Pisano T., Pruna D., Curia G., Cianchetti C., Pasqualetti M., Becchetti A., Guerrini R., and Casari G. Increased sensitivity of the neuronal nicotinic receptor α 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am. J. Hum. Genet. 79 (2006) 342-350
2. Butt C.M., Hutton S.R., Stitzel J.A., Balogh S.A., Owens J.C., and Collins A.C. A polymorphism in the α4 nicotinic receptor gene (Chrna4) modulates enhancement of nicotinic receptor function by ethanol. Alcohol. Clin. Exp. Res. 27 (2003) 733-742
3. Butt C.M., King N.M., Stitzel J.A., and Collins A.C. Interaction of the nicotinic cholinergic system with ethanol withdrawal. J. Pharmacol. Exp. Ther. 308 (2004) 591-599
4. Combi R., Dalpra L., Tenchini M.L., and Ferini-Strambi L. Autosomal dominant nocturnal frontal lobe epilepsy-a critical overview. J. Neurol. 251 (2004) 923-934
5. Combi R., Ferini-Strambi L., and Luisa Tenchini M. CHRNA2 mutations are rare in the NFLE population: Evaluation of a large cohort of Italian patients. Sleep Med. January (2008) [Epub ahead of print]
6. De Fusco M., Becchetti A., Patrignani A., Annesi G., Gambardella A., Quattrone A., Ballabio A., Wanke E., and Casari G. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat. Genet. 26 (2000) 275-276
7. Di Corcia G., Blasetti A., De Simone M., Verrotti A., and Chiarelli F. Recent advances on autosomal dominant nocturnal frontal lobe epilepsy: "understanding the nicotinic acetylcholine receptor (nAChR)". Eur. J. Paediatr. Neurol. 9 (2005) 59-66
8. Dobelis P., Marks M.J., Whiteaker P., Baloqh S.A., Collins A.C., and Stitzel J.A. A polymorphism in the mouse neuronal α4 nicotinic receptor subunit results in an alteration in receptor function. Mol. Pharmacol. 62 (2002) 334-342
9. Engel Jr. J., and International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 42 (2001) 796-803
10. Engel Jr. J. Report of the ILAE classification core group. Epilepsia 47 (2006) 1558-1568
11. Gu W., Bertrand D., and Steinlein O.K. A major role of the nicotinic acetylcholine receptor gene CHRNA2 in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is unlikely. Neurosci. Lett. 422 (2007) 74-76
12. Hirose S., Iwata H., Akiyoshi H., Kobayashi K., Ito M., Wada K., Kaneko S., and Mitsudome A. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology 53 (1999) 1749-1753
13. Klaassen A., Glykys J., Maguire J., Labarca C., Mody I., and Boulter J. Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 19152-19157
14. Leniger T., Kananura C., Hufnagel A., Bertrand S., Bertrand D., and Steinlein O.K. A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy. Epilepsia 44 (2003) 981-985
15. Marini C., and Guerrini R. The role of the nicotinic acetylcholine receptors in sleep-related epilepsy. Biochem. Pharmacol. 74 (2007) 1308-1314
16. Owens J.C., Balogh S.A., McClure-Begley T.D., Butt C.M., Labarca C., Lester H.A., Picciotto M.R., Wehner J.M., and Collins A.C. A4beta2* Nicotinic acetylcholine receptors modulate the effects of ethanol and nicotine on the acoustic startle response. Alcohol. Clin. Exp. Res. 27 (2003) 1867-1875
17. Phillips H.A., Scheffer I.E., Berkovic S.F., Hollway G.E., Sutherland G.R., and Mulley J.C. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nat. Genet. 10 (1995) 117-118
18. Phillips H.A., Scheffer I.E., Crossland K.M., Bhatia K.P., Fish D.R., Marsden C.D., Howell S.J., Stephenson J.B., Tolmie J., Plazzi G., Eeg-Olofsson O., Singh R., Lopes-Cendes I., Andermann E., Andermann F., Berkovic S.F., and Mulley J.C. Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24. Am. J. Hum. Genet. 63 (1998) 1108-1116
19. Phillips H.A., Marini C., Scheffer I.E., Sutherland G.R., Mulley J.C., and Berkovic S.F. A de novo mutation in sporadic nocturnal frontal lobe epilepsy. Ann. Neurol. 48 (2000) 264-267
20. Provini F., Plazzi G., Tinuper P., Vandi S., Lugaresi E., and Montagna P. Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases. Brain 122 (1999) 1017-1031
21. Rempel N., Heyers S., Engels H., Sleegers E., and Steinlein O.K. The structures of the human neuronal nicotinic acetylcholine receptor beta2- and α3-subunit genes (CHRNB2 and CHRNA3). Hum. Genet. 103 (1998) 645-653
22. Rozycka A., Skorupska E., Kostyrko A., and Trzeciak W.H. Evidence for S284L mutation of the CHRNA4 in a white family with autosomal dominant nocturnal frontal lobe epilepsy. Epilepsia 44 (2003) 1113-1117
23. Ryvlin P., Rheims S., and Risse G. Nocturnal frontal lobe epilepsy. Epilepsia 47 s2 (2006) 83-86
24. Scheffer I.E., Bhatia K.P., Lopes-Cendes I., Fish D.R., Marsden C.D., Andermann F., Andermann E., Desbiens R., Cendes F., Manson J.I., and Berkovic S.F. Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder. Lancet 343 (1994) 515-517
25. Steinlein O., Weiland S., Stoodt J., and Propping P. Exon-intron structure of the human neuronal nicotinic acetylcholine receptor α 4 subunit (CHRNA4). Genomics 32 (1996) 289-294
26. Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R., Scheffer I.E., and Berkovic S.F. A missense mutation in the neuronal nicotinic acetylcholine receptor α 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 11 (1995) 201-203
27. Steinlein O.K., Magnusson A., Stoodt J., Bertrand S., Weiland S., Berkovic S.F., Nakken K.O., Propping P., and Bertrand D. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum. Mol. Genet. 6 (1997) 943-947
28. Steinlein O.K., Stoodt J., Mulley J., Berkovic S., Scheffer I.E., and Brodtkorb E. Independent occurrence of the CHRNA4 Ser248Phe mutation in a Norwegian family with nocturnal frontal lobe epilepsy. Epilepsia 41 (2000) 529-535
29. Steinlein O.K. Genetic disorders caused by mutated acetylcholine receptors. Life Sci. 80 (2007) 2186-2190
30. Steinlein O.K. Human disorders caused by the disruption of the regulation of excitatory neurotransmission. Results Probl. Cell Differ. 44 (2008) 223-242
31. Stitzel J.A., Dobelis P., Jimenez M., and Collins A.C. Long sleep and short sleep mice differ in nicotine-stimulated 86Rb+ efflux and α4 nicotinic receptor subunit cDNA sequence. Pharmacogenetics 11 (2001) 331-339